Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection

Journal of Hepatology

Volumn 45, Issue 3, 2006, Pages 361-369

  Toan, Nguyen L ^a,b   Song, Le H ^c   Kremsner, Peter G ^b,d   Duy, Dinh N ^c   Binh, Vu Q ^e   Duechting, Anja ^a   Kaiser, Heike ^a   Torresi, Joseph ^f   Kandolf, Reinhard ^a   Bock, C Thomas ^a  

^a University Hospital of Tuebingen   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Tran Hung Dao Hospital   (Viet Nam)

^d ALBERT SCHWEITZER HOSPITAL   (Gabon)

^e 354 Hospital   (Viet Nam)

^f Victorian Infectious Diseases Service   (Australia)

Author keywords

Co infection; Hepatitis B virus; Hepatocellular carcinoma; Human parvovirus B19; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DNA DETERMINATION; DNA SEQUENCE; ERYTHEMA INFECTIOSUM; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; VIET NAM; VIRUS EXAMINATION; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANTIBODIES, VIRAL; COMORBIDITY; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE; VIETNAM; VIRAL LOAD;

EID: 33746766266     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.03.013     Document Type: Article

References (47)

1. Heegaard E.D., and Brown K.E. Human parvovirus B19. Clin Microbiol 15 (2002) 485-505
2. Berns K.I. Parvoviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology (1996), Lippincott-Raven, Philadelphia 2173-2197
3. Morinet F. Parvovirus B19 infection. Pathol Biol 40 (1992) 621-622
4. Zhi N., Zadori Z., Brown K.E., and Tijssen P. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318 (2004) 142-152
5. Cotmore S.F., McKie V.C., Anderson L.J., Astell C.R., and Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60 (1986) 548-557
6. Weigel-Kelley K.A., Yoder M.C., and Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102 (2003) 3927-3933
7. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J., Kodera T., Ishii T., et al. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106 (2005) 3449-3456
8. Brown K.E., Anderson S.M., and Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 (1993) 114-117
9. Cooling L.L., Koerner T.A.W., and Naides S.J. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 172 (1995) 1198-1205
10. Cotmore S.F., and Tattersall P. DNA replication in the autonomous parvoviruses. Semin Virol 6 (1995) 271-281
11. Karettnyi Y.V., Beck P.R., Markin R.S., Langnas A.N., and Naides S.J. Human parvovirus B19 infection in acute of fulminant liver failure. Arch Virol 144 (1999) 1713-1724
12. Poole B.D., Karetnyi Y.V., and Naides S.J. Parvovirus B19-induced apoptosis of hepatocytes. J Virol 78 (2004) 7775-7783
13. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L., et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet 1 (1983) 1378
14. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
15. Moore T.L. Parvovirus-associated arthritis. Curr Opin Rheumatol 12 (2000) 289-294
16. Bultmann B.D., Klingel K., Sotlar K., Bock C.T., Baba H.A., Sauter M., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34 (2003) 92-95
17. Kuhl U., Pauschinger M., Bock T., Klingel K., Schwimmbeck C.P., Seeberg B., et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108 (2003) 945-950
18. Bock C.T. Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy. Ernst Schering Res Found Workshop 55 (2006) 83-97
19. Dingli D., Pfizenmaier D.H., Arromdee E., Wennberg P., Spittell P.C., Chang-Miller A., et al. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356 (2000) 312-314
20. Finkel T.H., Torok T.J., Ferguson P.J., Durigon E.L., Zaki S.R., Leung D.Y., et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?. Lancet 343 (1994) 1255-1258
21. Barah F., Vallely P.J.S., Chiswick M.L., Cleator G.M., and Kerr J.R. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 358 (2001) 729-730
22. Naides S.J., Karetnyi Y.V., Cooling L.L.W., Mark R.S., and Langnas A.N. Human parvovirus B19 infection and hepatitis. Lancet 347 (1996) 1563
23. Yoto Y., Kudoh T., Haseyama K., Suzuki N., and Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 347 (1996) 868-869
24. Hillingso J.G., Jensen I.P., and Tom-Petersen L. Parvovirus B19 and acute hepatitis in adults. Lancet 351 (1998) 955-956
25. Drago F., Semino M., Rampini P., and Rebora A. Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 144 (1999) 1713-1724
26. He Z., Zhuang H., Wang X., Song S., Dong Q., Yan J., et al. Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection. J Med Virol 69 (2003) 59-65
27. Lee P., Hung C., Lin Y., Jan M., and Lei H. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients. Transplantation 73 (2002) 1635-1639
28. Sokal E.M., Melchior M., Cornu C., Vandenbroucke A.T., Buts J.P., Cohen B.J., et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favorable prognosis in young children. Lancet 325 (1998) 1739-1741
29. Langnas A., Markin R., Cattral M., and Naides S. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22 (1995) 1661-1665
30. Pardi D.S., Romero Y., Mertz L.E., and Douglas D.D. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 93 (1998) 468-470
31. Wong S., Young N.S., and Brown K.E. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187 (2003) 1581-1586
32. Hsu T.C., Chen T.Y., Lin M.C., Tzang B.S., and Tsay G.J. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20 (2005) 733-738
33. Nguyen TV, Truong XL, Nguyen TN, Phung TTY, Nguyen TN, Hoang CL et al. Hepatitis B virus infection in Vietnam. Reports of Institute of Hygien and Epidemic, Hanoi, Vietnam; 1995.
34. Song L.H., Binh V.Q., Duy D.N., Bock C.T., Kun J.F.J., Kremsner P.G., et al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28 (2003) 93-103
35. Song L.H., Binh V.Q., Duy D.N., Bock T.C., Kremsner P.G., Luty A.J., et al. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. J Med Virol 73 (2004) 244-249
36. Luo J.C., Hwang S.J., Lai C.R., Lu C.L., Li C.P., Tsay S.H., et al. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. J Gastroenterol Hepatol 13 (1998) 685-690
37. Bock C.T., Malek N.P., Tillmann H.L., Manns M.P., and Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 74 (2000) 2193-2202
38. Gerard C.J., Andrejka L.M., and Macina R.A. Mitochondrial ATP synthase 6 as an endogenous control in the quantitative RT-PCR analysis of clinical cancer samples. Mol Diagn 5 (2000) 39-46
39. Tschope C., Bock C.T., Kasner M., Noutsias M., Westermann D., Schwimmbeck P.L., et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111 (2005) 879-886
40. Cassinotti P., Burtonboy G., Fopp M., and Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53 (1997) 229-232
41. Pinho J.R.R., Alves V.A.F., Vieira A.F., Moralez M.O.S., Fonseca L.E.P., Guz B., et al. Detection of human parvovirus B19 in a patient with hepatitis. Brazilian J Med Biol Res 34 (2001) 1131-1138
42. Tsuda H. Liver dysfunction caused by parvovirus B19. Am J Gastroenterol 88 (1993) 1463
43. Eis-Hübinger A.M., Reber U., Abdul-Nour T., Glatzel U., Lauschke H., and Uwe Pütz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65 (2001) 395-401
44. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41 (2005) 771-778
45. Penna A., Chisari F.V., Bertoletti A., Missale G., Fowler P., Giuberti T., et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174 (1991) 1565-1570
46. Yim H.J., and Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43 (2006) 173-181
47. Ponnazhagan S., Woody M.J., Wang X.S., Zhou S.Z., and Srivastava A. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J Virol 69 (1995) 8096-8101